Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1681/ASN.2013121351

http://scihub22266oqcxt.onion/10.1681/ASN.2013121351
suck pdf from google scholar
C4378101!4378101 !25145931
unlimited free pdf from europmc25145931
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25145931 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid25145931
      J+Am+Soc+Nephrol 2015 ; 26 (4 ): 908-25
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury #MMPMID25145931
  • Bajwa A ; Rosin DL ; Chroscicki P ; Lee S ; Dondeti K ; Ye H ; Kinsey GR ; Stevens BK ; Jobin K ; Kenwood BM ; Hoehn KL ; Lynch KR ; Okusa MD
  • J Am Soc Nephrol 2015[Apr]; 26 (4 ): 908-25 PMID25145931 show ga
  • Sphingosine 1-phosphate (S1P), the natural sphingolipid ligand for a family of five G protein- coupled receptors (S1P1-S1P5Rs), regulates cell survival and lymphocyte circulation. We have shown that the pan-S1PR agonist, FTY720, attenuates kidney ischemia-reperfusion injury by directly activating S1P1 on proximal tubule (PT) cells, independent of the canonical lymphopenic effects of S1P1 activation on B and T cells. FTY720 also reduces cisplatin-induced AKI. Therefore, in this study, we used conditional PT-S1P1-null (PepckCreS1pr1(fl/fl)) and control (PepckCreS1pr1(w/wt)) mice to determine whether the protective effect of FTY720 in AKI is mediated by PT-S1P1. Cisplatin induced more renal injury in PT-S1P1-null mice than in controls. Although FTY720 produced lymphopenia in both control and PT-S1P1-null mice, it reduced injury only in control mice. Furthermore, the increase in proinflammatory cytokine (CXCL1, MCP-1, TNF-?, and IL-6) expression and infiltration of neutrophils and macrophages induced by cisplatin treatment was attenuated by FTY720 in control mice but not in PT-S1P1-null mice. Similarly, S1P1 deletion rendered cultured PT cells more susceptible to cisplatin-induced injury, whereas S1P1 overexpression protected PT cells from injury and preserved mitochondrial function. We conclude that S1P1 may have an important role in stabilizing mitochondrial function and that FTY720 administration represents a novel strategy in the prevention of cisplatin-induced AKI.
  • |Acute Kidney Injury/chemically induced/*prevention & control [MESH]
  • |Animals [MESH]
  • |Apoptosis/drug effects [MESH]
  • |Cell Respiration [MESH]
  • |Cisplatin [MESH]
  • |Drug Evaluation, Preclinical [MESH]
  • |Epithelial Cells/drug effects [MESH]
  • |Fingolimod Hydrochloride [MESH]
  • |Kidney Tubules, Proximal/*drug effects [MESH]
  • |Male [MESH]
  • |Mice, Inbred C57BL [MESH]
  • |Mitochondria/*drug effects [MESH]
  • |Mitochondrial Dynamics [MESH]
  • |Propylene Glycols/pharmacology/*therapeutic use [MESH]
  • |Receptors, Lysosphingolipid/*agonists/metabolism [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box